The high-THC debate: ‘This is a medical market. It shouldn’t be consumer driven’ by Steve Jones February 21, 2024February 21, 2024 Doctors should be cautious and pharmacists should be vigilant when dealing with high-strength flower amid doubts […]
Specialist warns of ‘hidden’ issue of addiction as evidence gap remains ‘huge’ by Steve Jones February 20, 2024February 20, 2024
Administrators slim down Epsilon board as investigations continue by Steve Jones February 15, 2024February 15, 2024
Growers’ worst nightmare: Hop Latent Viroid detected in Australia by Steve Jones February 15, 2024February 15, 2024
Cann I Help launches rapid access program to fast track medicine to patients in need by Steve Jones February 14, 2024February 14, 2024
Australia ‘watching closely’ as Israel launches Canada anti-dumping probe by Steve Jones February 8, 2024February 8, 2024
Hemp taskforce launches in NSW with aim to remove barriers and map out growth plan by Steve Jones February 8, 2024February 8, 2024
Emyria S3 CBD trial ‘on hold’ as firm stresses need to focus on revenue by Steve Jones February 7, 2024February 7, 2024
Clarity over German legal scheme paves way for AusCann-Eurocann deal by Steve Jones February 7, 2024February 7, 2024
Cannabis seeing ‘explosive growth’ but data reveals sales dogfight beyond the market leaders by Steve Jones February 1, 2024February 1, 2024
